BioNTech SE (BNTX) Current Leases (2021 - 2025)
BioNTech SE (BNTX) posted Current Leases of $52.4 million for Q4 2025, up 24.1% sequentially from $42.2 million in Q4 2024, and up 24.1% YoY from $42.2 million in Q4 2024.
BioNTech SE (BNTX) Current Leases (2021 - 2025) Analysis & Trends
BioNTech SE has reported Current Leases for 5 years, with the latest figure at $52.4 million in Q4 2025.
- Quarterly Current Leases rose 24.1% year-over-year to $52.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52.4 million (up 24.1% YoY) and the FY2025 annual result came in at $50.8 million, up 20.45% from the prior year.
- Current Leases climbed to $52.4 million in Q4 2025 per BNTX's latest filing, from $42.2 million in the prior quarter.
- Over five years, Current Leases peaked at $52.4 million in Q4 2025 and troughed at $30.2 million in Q4 2023.
- A 5-year average of $38.7 million and a median of $36.7 million in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases declined 17.68% in 2023, then surged 39.61% in 2024.
- Over 5 years, Current Leases stood at $31.9 million in 2021, then climbed by 15.08% to $36.7 million in 2022, then slipped by 17.68% to $30.2 million in 2023, then jumped by 39.61% to $42.2 million in 2024, then rose by 24.1% to $52.4 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $52.4 million, $42.2 million, and $30.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 52.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52.38 Mn |
| Dec 31, 2024 | 42.21 Mn |
| Dec 31, 2023 | 30.23 Mn |
| Dec 31, 2022 | 36.73 Mn |
| Dec 31, 2021 | 31.92 Mn |